Почетна › Рак (све врсте) › Тексас › San Antonio
Kliničke studije za Рак (све врсте) u gradu San Antonio, TX
Jedna studija za Рак (све врсте) traži učesnike na lokaciji u gradu San Antonio ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of YL242 in Subjects With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- US-207, San Antonio
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Тражи се учесникФаза 1/2
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Texas LLC - San Antonio, San Antonio
- Start San Antonio, LLC, San Antonio
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Тражи се учесникФаза 2/3
- Sam Clinical Research Center, San Antonio
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT San Antonio, San Antonio
PAS-004 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Тражи се учесникФаза 1
- Research Site #2, San Antonio
- Research Site, San Antonio
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Тражи се учесникФаза 3
- START San Antonio ( Site 0104), San Antonio
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Тражи се учесникФаза 1
- USA Clinical Trials, San Antonio
A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)
Тражи се учесникФаза 2
- START San Antonio ( Site 0220), San Antonio
A Study of ASP3082 in Adults With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
Тражи се учесникФаза 1
- START San Antonio, San Antonio
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- START, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Тражи се учесникФаза 2
- Mays Cancer Center ( Site 0039), San Antonio
Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
Тражи се учесникФаза 1
- NEXT Oncology ( Site 0151), San Antonio
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
A Study of PHN-012 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- PHN-012-001 Site, San Antonio
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Тражи се учесникФаза 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- GSK Investigational Site, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
Prostate Active Surveillance Study
Тражи се учесникОпсервациона студија
- University of Texas Health Science Center, San Antonio, San Antonio
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Тражи се учесникФаза 3
- Texas Oncology-San Antonio Cancer Care, San Antonio
- Texas Oncology - San Antonio Northeast, San Antonio
- Texas Oncology - San Antonio Stone Oak, San Antonio
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
Project: Every Child for Younger Patients With Cancer
Тражи се учесникОпсервациона студија
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- Site 01, San Antonio
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1
- NEXT Oncology San Antonio, San Antonio
- START- San Antonio, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- UT Health Mays Cancer Center, San Antonio
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
IDOV-Immune for Advanced Solid Tumors
Тражи се учесникФаза 1
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- START San Antonio, LLC., San Antonio
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- START San Antonio, San Antonio
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Тражи се учесникФаза 1
- GSK Investigational Site, San Antonio
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Тражи се учесникФаза 1/2
- NEXT Oncology, San Antonio
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology San Antonio, San Antonio
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- UT Health, San Antonio
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Тражи се учесникФаза 1
- NEXT Oncology, San Antonio
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Тражи се учесникФаза 1/2
- NEXT Oncology, San Antonio
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Тражи се учесник
- University of Texas Health Science Center at San Antonio, San Antonio
Studije za Рак (све врсте) u drugim gradovima
- Houston, TX124 студија
- New York City, NY105 студија
- Boston, MA90 студија
- Los Angeles, CA73 студија
- Nashville, TN65 студија
- Durham, NC61 студија
- Washington, DC60 студија
- Philadelphia, PA57 студија
- Arlington, VA52 студија
- Chicago, IL51 студија
- St. Louis, MO51 студија
- Atlanta, GA49 студија
Ostale studije u gradu San Antonio
- Немалоклетни карцином плућа60 студија
- Рак дојке45 студија
- Метастатски карцином44 студија
- Колоректални карцином43 студија
- Гојазност39 студија
- Dijabetes tipa 237 студија
- Гојазност34 студија
- Рак јајника33 студија
- Рак панкреаса33 студија
- Рак плућа27 студија
- Рак простате27 студија
- Карцином ендометријума27 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.